The U.S. District Court for the Eastern District of Texas held that the CFPB's amendments to its supervisory operations and examinations manual to include “discrimination” under “unfair, deceptive, or abusive acts or practices” exceeds the agency's authority under Dodd-Frank.
News & Insights
The U.S. Supreme Court agreed to consider a pair of whistleblower-initiated False Claims Act cases accusing two pharmacy operators of billing Medicare and Medicaid programs for prescription drugs at artificially high rates while charging non-governmentally insured customers lesser prices for those same drugs.
A jury returned a rare verdict in a "qui tam" False Claims Act matter, finding a pharmaceutical company liable for $61 million in damages arising out of purported misconduct involving the Medicaid Drug Rebate Program.
In AMG Capital Management, LLC, et al. v. Federal Trade Commission, the U.S. Supreme Court held that the FTC does not have the authority under Section 13(b) of the Federal Trade Commission Act to seek equitable monetary relief.
The U.S. District Court for the District of Columbia ordered the Small Business Administration to release the names, addresses and loan amounts for PPP loan recipients by November 19, 2020.